WallStSmart

Lineage, Inc. Common Stock (LINE)vsTexas Instruments Incorporated (TXN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Texas Instruments Incorporated generates 244% more annual revenue ($18.44B vs $5.36B). TXN leads profitability with a 29.1% profit margin vs -2.7%. TXN earns a higher WallStSmart Score of 72/100 (B).

LINE

Hold

39

out of 100

Grade: F

Growth: 4.0Profit: 3.0Value: 6.7Quality: 3.8
Piotroski: 5/9Altman Z: 0.81

TXN

Strong Buy

72

out of 100

Grade: B

Growth: 6.7Profit: 9.5Value: 4.3Quality: 7.8
Piotroski: 5/9Altman Z: 4.12
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

LINEUndervalued (+75.9%)

Margin of Safety

+75.9%

Fair Value

$161.27

Current Price

$39.96

$121.31 discount

UndervaluedFair: $161.27Overvalued

Intrinsic value data unavailable for TXN.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LINE1 strengths · Avg: 10.0/10
Price/BookValuation
1.1x10/10

Reasonable price relative to book value

TXN6 strengths · Avg: 9.5/10
Market CapQuality
$261.92B10/10

Mega-cap, among the largest globally

Return on EquityProfitability
32.4%10/10

Every $100 of equity generates 32 in profit

Operating MarginProfitability
37.8%10/10

Strong operational efficiency at 37.8%

Altman Z-ScoreHealth
4.1210/10

Safe zone — low bankruptcy risk

Profit MarginProfitability
29.1%9/10

Keeps 29 of every $100 in revenue as profit

Revenue GrowthGrowth
18.6%8/10

18.6% revenue growth

Areas to Watch

LINE4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
0.4%4/10

0.4% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Operating MarginProfitability
3.3%3/10

Operating margin of 3.3%

Return on EquityProfitability
-1.8%2/10

ROE of -1.8% — below average capital efficiency

TXN3 concerns · Avg: 3.3/10
PEG RatioValuation
1.614/10

Expensive relative to growth rate

Price/BookValuation
15.6x4/10

Trading at 15.6x book value

P/E RatioValuation
49.2x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : LINE

The strongest argument for LINE centers on Price/Book.

Bull Case : TXN

The strongest argument for TXN centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 29.1% and operating margin at 37.8%. Revenue growth of 18.6% demonstrates continued momentum.

Bear Case : LINE

The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.

Bear Case : TXN

The primary concerns for TXN are PEG Ratio, Price/Book, P/E Ratio. A P/E of 49.2x leaves little room for execution misses.

Key Dynamics to Monitor

LINE profiles as a turnaround stock while TXN is a growth play — different risk/reward profiles.

TXN is growing revenue faster at 18.6% — sustainability is the question.

TXN generates stronger free cash flow (844M), providing more financial flexibility.

Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.

Bottom Line

TXN scores higher overall (72/100 vs 39/100), backed by strong 29.1% margins and 18.6% revenue growth. LINE offers better value entry with a 75.9% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Lineage, Inc. Common Stock

REAL ESTATE · REIT - INDUSTRIAL · USA

Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm focused on regenerative medicine, specifically developing cutting-edge cell therapy solutions for treating debilitating conditions, including ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust network of strategic collaborations, Lineage is poised to transform patient care through innovative therapeutic interventions. The company's commitment to advancing its diverse product pipeline and expediting clinical research positions it as an attractive investment opportunity for institutional investors seeking to engage in the forefront of healthcare advancements.

Visit Website →

Texas Instruments Incorporated

TECHNOLOGY · SEMICONDUCTORS · USA

Texas Instruments Incorporated (TI) is an American technology company headquartered in Dallas, Texas, that designs and manufactures semiconductors and various integrated circuits, which it sells to electronics designers and manufacturers globally. It is one of the top 10 semiconductor companies worldwide based on sales volume.

Want to dig deeper into these stocks?